RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, and Janssen. All content chosen by RheumNow & its faculty.

Video: Personalization of PsA Treatment: Dr. Robert Chao (@doctorRBC ) #EULAR2021 https://t.co/7FmZ4BzHwp

• https://bit.ly/2SW76L7

Combination vs. Sequential Therapy for the Treatment of Lupus Nephritis by Dr. Kathryn Dao ( @KDAO2011 ) #EULAR2021 https://t.co/0d1bxBlUS0

• https://bit.ly/3pqQ9EX

Video: How Can We Help our Patients with Sjogren's? Dr. Janet Pope (@Janetbirdope ) #EULAR2021 https://t.co/dHIrEBs1Rc

• https://bit.ly/3fWmAIg

Artificial intelligence brings clarity to early bony changes in inflammatory arthritis by Dr. David Liew https://t.co/RPH3k2Gz0W #EULAR2021

• https://bit.ly/3pnSKiE

RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, & Janssen. All content chosen by RheumNow and its Faculty.

POS0192 BL prognostic factors of achieving MDA in 77 early PsA treated #T2T strategy. See forest plot below. Rather sobering results. It seems nearly fullfilling MDA at baseline is associated with fullfilling MDA at 12 months. More useful predictors needed #EULAR2021 @RheumNow https://t.co/7U65Nt3Woj

How common is #burnout among rheumatologists? Dr Maldonado surveyed N=297 in Latin America using Maslach Burnout Inventory. 57% had burnout. Associated with younger,long hours,⬇️satisfaction, depression,⬇️wage,comorbidities. Let's support each other #EULAR2021 #POS0302 @RheumNow https://t.co/QOA2xsDZen